Neo-Sensitabs Susceptibility Testing

Size: px
Start display at page:

Download "Neo-Sensitabs Susceptibility Testing"

Transcription

1 Neo-Sensitabs Susceptibility Testing Potencies according to EUCAST and CLSI Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the laboratory Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

2 Neo-Sensitabs - Products in Alphabetical Order Packaging Neo-Sensitabs are packed in cartridges containing 1 x tablets Minimum sale: 1 package containing 5 cartridges (2 tablets) Please order per package on your order sheets REF No. Antibiotic Code A Potency µg 2-8 EUCAST CLSI Amikacin AMI30 30 x x 70112N Amoxycillin AMOXY 30 x Amoxycillin + Clavulanate AMC n x Amoxycillin + Clavulanate AMC n x x Ampicillin AMP.2 2 x Ampicillin AMP10 10 x x Ampicillin + Sulbactam SAM x Azithromycin AZI15 15 x x Aztreonam AZT30 30 x x B 70812N Bacitracin BACIT 40 C 612 Cefaclor CCL30 30 x x Cefazolin CFZ30 30 x Cefepime FEP30 30 n x x Cefepime + Clavulanate FEP+C n Cefixime CFM.5 5 x x Ceftolozane + Tazobactam C / T x Cefotaxime CTX05 5 x Cefotaxime CTX30 30 x Cefotaxime + Clavulanate CTX+C n Cefotaxime + Boronic Acid CTXBO Ceftazidime + Boronic Acid CAZBO N Cefoxitin CFCID Cefoxitin CFO30 30 x x Cefpodoxime CPD10 10 n x x Cefpodoxime + Clavulanate CPD+C 10+1 n Ceftaroline CPT30 30 x Ceftaroline CPT. 5 5 x Ceftazidime CAZ10 10 x Ceftazidime CAZ30 30 x Ceftazidime + Clavulanate CZ+CL n Ceftibuten CBT30 30 x Ceftizoxime ZOX30 30 x Ceftobiprole CFBIP 30 n x Ceftriaxone CTR30 30 x x Cefuroxime CXM30 30 x x 72812N Cephalexin CFLEX 30 x Cephalothin CEP30 30 x 73012N Cephradine CFRAD 60 x Chloramphenicol CLR30 30 x x Ciprofloxacin CIPR Ciprofloxacin CIRP5 5 x x Clarithromycin CLA15 15 x x Clindamycin CLI.2 2 x x Colistin CO x x D 80312N Daptomycin DAPCa 30 (+100) Doxycycline DOX30 30 x x Doripenem DOR10 10 x x Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

3 REF No. Antibiotic Code E Potency µg 2-8 EUCAST CLSI Ertapenem ETP10 10 n x x Erythromycin ERY15 15 x x F Fosfomycin FO n x Fucidin FUC10 10 x x 74312N Fucidin FUCID 100 x 74412N Furazolidone FURAZ x G Gentamicin GEN10 10 x x Gentamicin GEN30 30 x 43012N Gentamicin GN2 2 x x I Imipenem IMI10 10 x x Imipenem + EDTA IM10E K Kanamycin KAN30 30 x 43112N Kanamycin KA0 0 x L 74812N Levofloxacin LEVOF 5 x x Linezolid LIZ10 10 x 75112N Linezolid LINEZ 30 x M Mecillinam MEC10 10 x x Meropenem MRP10 10 x x Metronidazole MTR.5 5 x x 75512N Metronidazole MTR Minocycline MIN30 30 x x 79812N Moxifloxacin MOXIF 5 x x 75712N Mupirocin MUPIR Mupirocin MP x x N Nalidixan NAL30 30 x x 75912N Neomycin NEOMY Netilmicin NET10 10 x Netilmicin NET30 30 x Nitrofurantoin NI x Nitrofurantoin NI Nitrofurantoin NI x 76212N Norfloxacin NORFX 10 x x 76312N Novobiocin NOVO5 5 x O Ofloxacin OFL.5 5 x x Oxacillin OXA.1 1 x x P 76912N Pefloxacin (stop production) PEFLX 10 x 77012N Pefloxacin PEF.5 5 x Penicillin (Penicillin G) PENG1 1 x x Penicillin (Penicillin G) PEN10 10 x 77212N Pipemicid Acid PIPEM 30 x Piperacillin PIP30 30 x 77312N Piperacillin PIPRA 100 x Piperacillin + Tazobactam PTZ x 77412N Piperacillin + Tazobactam PI+TZ x 77512N Polymyxins (Colistin) CO1 1 Q 80012N Quinupristin - Dalfopristin SYN15 15 x x Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

4 REF No. Antibiotic Code R Retapamulin RETA.2 2 Potency µg 2-8 EUCAST CLSI Rifampicin RIF.5 5 x x S 77812N Spectinomycin SPECT 200 x Streptomycin STR10 10 x 44712N Streptomycin ST0 0 x 78112N Sulphonamides SULFA 240 x T Teicoplanin TPN30 30 x x 80112N Telithromycin TEL15 15 x x 78312N Temocillin TEMOC 30 n x x Tetracyclines (Oxytetracycline) TET30 30 x x Ticarcillin TIC75 75 n x x Ticarcillin + Clavulanate TIM n x x 80412N Tigecycline TIG15 15 x x Tobramycin TOB10 10 x x Trimethoprim TRIM5 5 x x Trimethoprim + Sulfamethoxazole SxT x x Trimethoprim 2,5 V Vancomycin VAN.5 5 x Vancomycin VAN30 30 x n= Store at 2 8 C Our product have 2 years to 5 years of expire date. For more product information When cartridges are opened and placed in a dispenser: Cartridges to be kept at room temperature: To be used within the next 12 months. ncartridges to be kept at 2-8 degrees: To be used within 2 months. Accessories REF No Product Dispenser 1 cartridge single dispenser Dispenser 7 cartridges round Petri dishes of 9 cm diameter Dispenser 12 cartridges round Petri dishes of cm diameter Dispenser 16 cartridges square Petri dishes of 12 x 12 cm ID Plate - Zone readings 901 Zone Measuring stick Neo-SensitabsTM Susceptibility Rosco Diagnostica A/S Product list 2014

5 Diatabs Identification of Bacteria and Fungi Product list Diatabs TM Rosco Diagnostica A/S Product list

6 Diatabs - Products in Alphabetical Order REF Tablets Product Diatabs 2-8 Code No. per vial A Tablet in mm Adonitol ADO Alkaline Phosphatase n Alk P Alpha-Galactosidase α-gal Alpha-Glucosidase α-glu l-arabinose n ARA Arginine Dihydrolase ADH 6 B Bacitracin Low 0.4 U BaL 6** 511 Beta-Glucosidase β-glu Beta-Glucuronidase PGUA Beta-Lactamase n ACIDO Beta-Xylosidase β-xyl Bile Esculin BE Boronic Acid BORON 25 9** Brilliant Green 100 µg BrG 6** C C µg C * Cloxacillin n CLOXA 25 9** Cycloheximide CYC 9** D Deferoxamine 2 µg DEFRX 9** Dipicolinic Acid D.P.A. 25 9** d-xylose n XYL 25 6 E Esculin Hydrolysis ESC 6 F Factor V n 6** Factor X n 6** Factor X + V n 6** G Gamma-Glutamyl Aminopeptidase g-glu Glucose GLU 6 H Hippurate Hydrolysis HIP 6 I 591 Indoxyl Acetate n IAC Inulin INU 6 L Lactose LAC LDC/Indole (Lysine Decarboxylase/Indole) LDC/IND Leucine Aminopeptidase LAP Lysine Decarboxylase LDC Diatabs TM Rosco Diagnostica A/S Product list

7 REF Tablets Product Diatabs 2-8 Code No. per vial M Tablet in mm Maltose MAL Mannitol MAN Mannose MSE Metronidazole 5 µg MTR.5 9** Metronidazole µg MTR 9** N Nitrate Reduction NO3 6 O O/129 (Vibriostaticum) 1 µg O/ ** 311 ONPG (Beta-Galactosidase) ONPG Optochin 10 µg OPT 6** Ornithine Decarboxylase ODC Oxgall 1000 µg OXG 6** Oxidase OXI 6 P PGUA/Indole (Beta-Glucuronidase/Indole) PGUA/IND Porphyrin (d-ala) ALA Proline Aminopeptidase n PRO Ps. aeruginosa Screen 80 µg PSAER 9** Pyrazinamidase PZA Pyrrolidonyl Aminopeptidase PYR 6 R l-rhamnose RHAM 6 S S.P.S µg SPS 6** Sorbitol SOR Sucrose SUC 6 T TDA or Indole (Tryptophan Deaminase or Indole) TDA or IND Tellur 0 µg TEL 6** Trehalose TRE Tributyrin n TRIB Trypsin TRYP 6 U Urease URE Urease/Indole URE/IND Urease/TDA URE/TDA 6 V Voges-Proskauer VP 6 n = Store at 2 8 C ** Diatabs tablets to be used on agar media for more information: (Diatabs User s Guide) Diatabs TM Rosco Diagnostica A/S Product list

8 Reagents REF NO Product Reagents Stored at 2 8 C ML per sales Unit Ninhydrin 3,5% solution n 20 ml Kovac s Reagent n 20 ml Aminopeptidase reagent n 20 ml N-N-Dimethyl-a-naphtyl. n 20 ml Sulfalinic Acid n 20 ml CE Marking All products are CE marked according to the European Directive 98/79/EC for In Vitro Diagnostic Medical Devices. Instructions For Use The relevant Instructions for use of each product are made freely available on our Website: in 7 12 different European languages. Diatabs User s Guide The latest version of the Diatabs User s Guide is downloadable from our website Diatabs TM Rosco Diagnostica A/S Product list

9 Neo-Sensitabs Antifungal Agents Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the clinic Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of Neo-Sensitabs Antifungal Agents Rosco Diagnostica A/S Product list 2014

10 Neo-Sensitabs Antifungal Agents- Products in Alphabetical Order Packaging Neo-Sensitabs Antifungals are packed in cartridges containing 1 x tablets Minimum sale: 1 package containing 5 cartridges (2 tablets) Please order per package on order sheets REF No. Product Code Potency N Amphotericin B AMPHO 10 n 82412N Caspofungin CASP5 5 n 81112N Ciclopirox CICLO 81212N Clotrimazole CTRIM N Econazole ECONZ N Fluconazole FLUCZ N Fluorocytosine FLU N Itraconazole ITRAC N Ketoconazole KETOC N Miconazole MICOZ N Nystatin NYSTA 82612N Posaconazole POSAC N Terbinafine TERBI N Voriconazole VOR.1 1 n = Store at 2 8 C Instructions for Use Neo-Sensitabs The Instructions for Use are made freely available on our web site It can be downloaded in PDF format in different European languages. CE Marking All products - except the Veterinary Antimicrobials - are CE marked according to The European Directive 98 /79/ EC for In Vitro Diagnostic Medical Devices. For more product information go to Rosco website Neo-Sensitabs Antifungal Agents Rosco Diagnostica A/S Product list 2014

11 Kits for Detection of Resistance Mechanisms Product list 2014 Unique characteristics ensure that NEO-SENSITABS are ideal for use in the laboratory Susceptibility testing with NEO-SENSITABS practice is performed according CLSI and EUCAST guidelines. Minimum orders for kits are 1 package. Rosco Diagnostica is the leader in the field of phenotypic methods for detection of Kits Product list Rosco Diagnostica A/S

12 Screening and Confirmation of ESBL s REF no. Product Tests pr. kit Detection of: Total ESBL Confirm Kit (EUCAST) Cefotaxime Cefotaxime + Clavulanate Ceftazidime Ceftazidime + Clavulanate Cefepime Cefepime + Clavulanate ESBL ESBL Confirm (acc. to CLSI) Kit Cefotaxime Cefotaxime + Clavulanate Ceftazidime Ceftazidime + Clavulanate ESBL ESBL Confirm (Chrom. AmpC) Kit (EUCAST) Cefepime Cefepime + Clavulanate 100 ESBL New Rapid ESBL Screen Kit Cefotaxime + tazobactam + Indicator Cefotaxime + Indicator ESBL Screening and Confirmation of ESBL+AmpC REF no. Product Tests pr. kit Detection of: ESBL + AmpC Screen Kit Cefotaxime Cefotaxime + Clavulanate Cefotaxime + Cloxacillin Cefotaxime + Clavulanate + Cloxacilin ESBL + AmpC Total ESBL + AmpC Confirm Kit Cefotaxime + Cloxacillin Cefotaxime + Clavulanate Ceftazidime + Cloxacillin Ceftazidime + Clavulanate Cefotaxime + Cloxacillin + Clavulanate Ceftazidime + Cloxacillin + Clavulanate ESBL + AmpC Kits Product list Rosco Diagnostica A/S

13 Screening and Confirmation of Carbapenemases REF no. Product Tests pr. kit Detection of: Rapid CARB Screen Kit Imipenem + Indicator (CARB) Diatabs CARB Negative Control Diatabs Carbapenemases Enterobacteriaceæ P. aeruginosa KPC and MBL Confirm Kit (EUCAST) Meropenem Meropenem + Dipicolinic Acid Meropenem + Phenylboronic Acid Meropenem + Cloxacillin Carbapenemases Enterobacteriaceae Triple disk, for detection of KPC + MBL Meropenem + Phenylboronic + Dipicolinic acid Carbapenemases KPC, MBL and OXA-48 Confirm Kit Meropenem Meropenem + Dipicolinic acid Meropenem + Cloxacillin Meropenem + Phenylboronic acid Temocillin Carbapenemases Enterobacteriaceae KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit Meropenem Meropenem + Phenylboronic acid Meropenem + Cloxacillin High Imipenem Dipicolinic acid Carbapenemases P. aeruginosa/acinetobacter Total MBL Confirm kit Imipenem Imipenem + EDTA Imipenem + Dipicolinic acid Meropenem Dipicolinic acid MBL all species New OXA-48+CARB Screen kit (30-60 min) Imipenem + Brthymol Blue Ertapenem + Brthymol Blue Negative Control Blue Carbapenemases All species Lysis buffer Not needed Confirmation of AmpC s Kits Product list Rosco Diagnostica A/S

14 REF no. Product Tests pr. kit Detection of: AmpC Confirm Kit Cefotaxime Cefotaxime + Cloxacillin Ceftazidime Ceftazidime + Cloxacillin AmpC Other Kits REF no. Product Tests pr. kit Detection of: Detection of hgisa,gisa,vre,daptomycin resistance Vancomycin Teicoplanin Daptomycin Staphylococci Enterococci Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter COLISTIN Prediffusion 100 MDR Gram negatives Urin Kit Privat Praksis Ampicillin Ciprofloxacin Mecillinam Nitrofurantoin Sulphonamide Trimethoprim Beta-Glucuronidase Susceptibility testing urines All products are CE marked according to the European Directive 98/79/EC for In Vitro Diagnostic Medical Devices. Detection of resistance mechanisms User s Guide The latest version of detection of resistance mechanisms User s Guide is downloadable from our website. Minimum orders for kits are 1 package Kits Product list Rosco Diagnostica A/S

15 AmpC Confirm Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 4 cartridges, formulated for maximum stability, each containing approximately tablets: Cefotaxime 30 µg, coded CTX30 Cefotaxime 30 µg + Cloxacillin, coded CTXCX Ceftazidime 30 µg, coded CAZ30 Ceftazidime 30 µg + Cloxacillin, coded CAZCX Quality Control As positive Q. C. stains the following may be used: Enterobacter cloacae NCTC 13406, AmpC positive Enterobacter cloacae ATCC BAA 1143, Amp C positive E. coli ATCC is a negative Q. C. stain All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL,AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, , Edquist P et al : Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32, , AmpC Cefotaxime 30 µg Ceftazidime30 µg CTX30 CAZ30 CTXCX 5mm - AmpC CAZCX - 5mm AmpC Confirm Kit Ref Okt. 2013

16 Susceptibility testing of Antifungals REF NO. PRODUCT Mueller Hinton agar BBL - II ANTIFUNGAL AGENTS REF NO. PRODUCT CODE POTENCY STORE N Amphotericin B AMPHO 10 n 82412N Caspofungin CASP5 5 n 81112N Ciclopirox CICLO 81212N Clotrimazole CTRIM N Econazole ECONZ N Fluconazole FLUCZ N Fluorocytosine FLU N Itraconazole ITRAC N Ketoconazole KETOC N Miconazole MICOZ N Nystatin NYSTA 82612N Posaconazole POSAC N Terbinafine TERBI N Voriconazole VOR.1 1 PACKAGING The cartridges contain tablets. Packed in boxes containing 1 x 5 cartridges = 2 tablets. STORAGE Our product have 2 years to 5 years of expire date. When cartridge are opened and placed in a dispenser: Cartridges to be kept at room temperature: To be used within the next 12 months. Cartridges to be kept at 2-8 : To be used within 2 months. Product list 2013 Neo-Sensitabs Susceptibility Testing Potencies according to EUCAST and CLSI Okt. 2013

17 Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The prediffusion method is very useful for testing high molecular antimicrobials. Content and formulation 2 cartridges of COLISTIN Prediffusion Neo-Sensitabs, formulated for maximum stability, each containing tablets. Totaling 100 tests Quality Control As Q. C. strains the following may be used: E. coli ATCC Ps. aeruginosa ATCC All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Boyen F et al: Disk prediffusion is a reliable method for testing Colistin susceptibility in porcine E. coli strains. Vet Microbiol 144, , Nastro M et al Evaluation of the prediffusion method for Colistin in K. pneumonia. Rev Argent Microbiol 44, supl1, P40, 2012 (Spanish) COLISTIN Prediffusion Sensitive Intermediate Resistant Enterobacteriaceae 16 mm mm < 12 mm Ps aeruginosa 16 mm mm < 12 mm Acinetobacter spp. 20 mm mm < 14 mm Detection of COLISTIN resistance in Enterobacteriaceae, P. aeruginosa and Acinetobacter Ref Okt. 2013

18 Detection of hgisa, GISA, VRE and Daptomycin susceptibility Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The prediffusion method is very useful for testing high molecular antimicrobials. Content and formulation 3 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Vancomycin 30 µg, coded VAN30 Teicoplanin 30 µg, coded TEI30 Daptomycin 30 µg, coded DAP30 All products from Rosco Diagnostica A/S are Quality Control marked in compliance As Q. C. strains the following may be used: with the European Union Staph aureus ATCC ; hvisa and Daptomycin susceptible directive 98/79/EC for Staph aureus AST 403, GISA and Daptomycin susceptible In Vitro Diagnostic Medical Enterococcus faecalis ATCC 51299, Van B. Staph aureus AST 408, GISA and Daptomycin resistant Devices. References Nielsen SV,Casals JB: Detection of decreased susceptibility to glycopeptides in S. aureus using tablet(disc) prediffusion.presented at ECCMID Koeth L et al: Multisite evaluation of the Daptomycin Neo-Sensitab prediffusion method against 20 S. aureus.presentation P-1065, ECCMID Vancomycin 30 ug Teicoplanin 30 ug Daptomycin 30 ug hgisa < 20 mm or < 20 mm GISA < 20 mm and < 20 mm < 5mm VRE Van A no Zone No zone Van B < 16mm(hazy) > 20 mm Van C < 12 mm (sharp) > 20 mm Daptomycin resistance Staphylococci < 20 mm Enterococci no zone Detection of hgisa, GISA, VRE and Daptomycin susceptibility Ref Okt. 2013

19 ESBL + AmpC Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 4 cartridges, each containing approximately tablets, formulated for maximum stability: Cefotaxime 30 µg, coded CTX30 Cefotaxime 30 µg + Clavulanate, coded CTX+C Cefotaxime 30 µg + Cloxacillin, coded CTXCX Cefotaxime 30 µg + Clavulanate + Cloxacillin, coded CTXCC Quality Control As positive Q. C strains the following may be used: Enterobacter cloacae NCTC 13406, Amp C positive Enterobacter cloacae ATCC BAA 1143, Amp C positive Klebs. pneumoniae ATCC ESBL positive All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL,AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, , Edquist P et al : Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32, , ESβL AmpC ESβL + AmpC CTX+C or B CTXCC D CTXCX or C CTXCC D CTX+C and B CTXCC D Cefotaxime CTX30 A 5 mm - 5 mm - <5 mm (AmpC) - Cefotaxime + Clavulanate CTX+C B - <5 mm - 5 mm - 5 mm (AmpC) Cefotaxime + Cloxacillin CTXCX C - 5 mm - <5 mm - 5 mm (ESBL) ESBL + AmpC Screen Kit Ref Okt. 2013

20 Total ESBL + AmpC Confirm Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Content and formulation 6 cartridges of tablets, formulated for maximum stability, each containing tablets: Cefotaxime + Cloxacillin, coded CTXCX Cefotaxime + Clavulanate, coded CTX+C Ceftazidime + Cloxacillin, coded CAZCX Ceftazidime + Clavulanate, coded CAZ+C Cefotaxime + Cloxacillin + Clavulanate, coded CTXCC Ceftazidime + Cloxacillin + Clavulanate, coded CAZCC Quality Control As positive Q. C. stains the following may be used: Enterobacter cloacae NCTC 13406, AmpC positive Klebs. pneumoniae ATCC , ESBL positive Enterobacter cloacae ATCC BAA-1143 AmpC positive All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESB, AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, , Edquist P et al: Phenotypic detection of plasmid-acquired AmpC in E. coli- evaluation of screening criteria and performance of 2 commercial methods for the phenotypic confirmation of AmpC production Eur J Clin Microbiol Infect Dis 32, , Enterobacteriaceae Cefotaxime + Cloxacillin + Clavulanate CTXCC Ceftazidime + Cloxacillin + Clavulanate CAZCC Cefotaxime + Cloxacillin >= 5 mm and/or - ESBL Ceftazidime + Cloxacillin >= 5 mm AmpC Cefotaxime + Clavulanate >= 5 mm and/or - Ceftazidime + Clavulanate >= 5 mm- Cefotaxime + Cloxacillin >= 5 mm and ESBL + AmpC Cefotaxime + Clav Ceftazidime + Cloxacillin >= 5 mm >= 5 mm and Ceftazidime + Clav >= 5 mm Total ESBL + AmpC Confirm Kit Ref Okt. 2013

21 ESBL Confirm Kits Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation ESBL Confirm (acc. to CLSI/EUCAST) Kit (98011) Comprises one cartridge ( tests) each of the following Cefotaxime 30 µg Cefotaxime 30 µg + Clavulanate Ceftazidime 30 µg Ceftazidime 30 µg + Clavulanate Testing of Enterobacteriaceae Group 1 (without chromosomal AmpC) according to CLSI/EUCAST. ESBL Confirm (Chrom. AmpC) Kit (98012) It comprises two cartridges (100 tests) each of the following: Cefepime 30 µg Cefepime 30 µg + Clavulanate Testing of Enterobacteriaceae Group 2 (possessing chromosomal AmpC) according to EUCAST. Total ESBL Confirm Kit (98014) Comprises one cartridge ( tests) each of the following: Cefotaxime 30 µg Cefotaxime 30 µg + Clavulanate Ceftazidime 30 µg Ceftazidime 30 µg + Clavulanate Cefepime 30 µg Cefepime 30 µg + Clavulanate Testing of any kind of Enterobacteriaceae, including chromosomal AmpC producers. All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Quality Control As positive Q.C. strains the following may be used: Klebsiella pneumoniae ATCC ,ESBL positive,(except cefepime) Enterobacter cloacae NCTC 13464, ESBL positive (use Cefepime and FEP+C) References Hansen F et al: Evaluation of Rosco Neo-Sensitabs for phenotypic detection and subgrouping of ESBL, AmpC and carbapenemase-producing Enterobacteriaceae. APMIS 120, , Reuland E.A.et al: High prevalence of ESBL-producing Enterobacteriaceae carriage in Dutch community patients with gastrointestinal complaints Clin Microbiol Infect 19, , ESBL Confirm kits Ref Okt. 2013

22 KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The kit is intended for detection of the carbapenemases; KPC and MBL in Pseudomonas aeruginosa and MBL in Acinetobacter spp. Content and formulation 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Meropenem 10 µg + Phenylboronic Acid (KPC and AmpC inhibitor), coded MRPBO Meropenem 10 µg + Cloxacillin High (AmpC inhibitor), coded MPCXH All products from Rosco Imipenem 10 µg, coded IMI10 Diagnostica A/S are Dipicolinic acid (DPA) marked in compliance Quality Control As positive Q. C. strains the following may be used: P. aeruginosa ATTC 10145/CCUG 59626, MBL positive K. pneumoniae CCUG 58547, MBL positive K. pneumoniae NCTC 13439, MBL positive K. pneumoniae CCUG 56233, KPC positive K. pneumoniae NCTC 13438, KPC positive References Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Dongeun Yong et al: Evaluation of double-disk potentiation tests using Dipicolinic acid for detection of MBL-producing Pseudomonas spp and Acinetobacter spp. J. Clin. Microbiol, , Miriagou V et al: Detecting VIM-1 production in P. mirabilis by an Imipenem-Dipicolinic acid double disk synergy test: J. Clin Microbiol 48, , 2010 KPC MβL Mc Conkey agar Meropenem + Phenylboronic MRPBO Meropenem + Cloxacillin High MPCXH Meropenem 10 µg 4mm and < 3 mm P. aeruginosa MRP10 Meropenem + Cloxacillin High 4 mm MPCXH P. aeruginosa Imipenem - - Synergism Acinetobacter 10 µg IMI Synergism DPA KPC/MBL in P. aeruginosa/acinetobacter Confirm Kit Ref Okt. 2013

23 KPC/Metallo-β-Lactamase Confirm Kit KPC/MBL and OXA-48 Confirm Kit Meropenem+Boronic Acid+Dipicolinic Acid Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. The kit is intended for detection of the carbapenemases; KPC, MBL and OXA-48 in Enterobacteriaceae Content and formulation 4 or 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Meropenem 10 µg + Phenylboronic Acid (KPC and AmpC inhibitor), coded MRPBO Meropenem 10 µg + Cloxacillin (AmpC inhibitor), coded MRPCX Meropenem 10 µg + Dipicolinic acid (Metallo-β-Lactamase inhibitor), coded MRPDP Temocillin 30 ug (only in the OXA-48 Confirm kit 98015) Quality Control As positive Q. C. strains the following may be used: Klebs. pneumoniae NCTC 13438, KPC positive Klebs. pneumoniae NCTC 13439, MBL positive Klebs. pneumoniae ATCC BAA-1705, KPC positive Klebs. pneumoniae ATCC BAA-2146, MBL positive As negative Q.C strain the following may be used: Klebs. pneumoniae ATCC All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. References Giske CG et al: A sensitive and specific phenotypic assay for detection of MBL and KPC in K. pneumoniae with the use of meropenem disks supplemented with phenylboronic acid,dipicolinic acid and cloxacillin.clin Microbiol Infect 17, ,2011. Ambrettii S et al: Evaluation of phenotypic and genotypic approaches for the detection of Class A and Class B carbapenemases in Enterobacteriaceae.Microbial Drug Res 19, , Miriagou V et al: Combined disk methods for the detection of KPC and/or VIM positive K. pneumoniae: improving reliability for the double carbapenemase producers.clin Microbiol Infect E412-E415,2013 Giakkoupi P et al: Evaluation of the modified KPC+MBL Confirm kit for the phenotypic detection of Class A and B carbapenemases in K. pneumoniae isolates. Presented at the ECCMID KPC/Metallo-β-Lactamase Confirm Kit Ref KPC/MBL and OXA-48 Confirm Kit Ref Meropenem+Boronic Acid+Dipicolinic Acid Ref Oct. 2013

24 AmpC + porin loss ESBL + porin loss (a) KPC MβL OXA-48 and similars OXA-48 + ESBL (a) Meropenem 10 µg MRP10 Meropenem 10 µg MRP10 Meropenem 10 µg MRP10 Meropenem + Cloxacillin (MRPCX) Meropenem 10 µg MRP10 Meropenem 10 ug MRP10 Meropenem 10 ug MRP10 Meropenem + Phenylboronic MRPBO 4mm and Meropenem + DPA MRPDP Meropenem + Cloxacillin MRPCX Temocilin 30 µg 3 mm 5mm 12mm 3 mm 3 mm 3 mm 12mm 4mm 3 mm 3 mm Variable 4mm < 4mm 5mm 3 mm Variable 3 mm 3 mm 3 mm 3 mm 3 mm 3 mm No zone of inhibition No zone of inhibition Triple Disk MER + DPA + BO double inhibitor KPC MRPDP 4 mm MBL MRPBO 4 mm KPC + MBL MRPDP MRPBO 4 mm and 4 mm KPC/Metallo-β-Lactamase Confirm Kit Ref KPC/MBL and OXA-48 Confirm Kit Ref Meropenem+Boronic Acid+Dipicolinic Acid Ref Oct. 2013

25 Rapid CARB Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro screening of carbapenemase producing bacteria. The method is valid for Enterobacteriaceae and Pseudomonas aeruginosa. Content and formulation Two vials with 6 mm tablets; Imipenem + Indicator (CARB), formulated for maximum stability, each containing 25 tablets equivalent to a total of tests: One vial with 6 mm. tablets: CARB Negative Control Diatabs, tablets. Interpretation of results A change of color from red to yellow indicates a positive reaction, indicating that the test strain possesses a carbapenemase. If the reaction is positive after 30 minutes or 1 hour, it is not necessary to incubate further. In most cases, a carbapenemase is detected in 30 min. Please notice: Some Enterobacteriaceae producing OXA 48 (or similar), showing MIC s for Imipenem <= 0.5 µg / ml may show a negative result with Rapid CARB Screen Kit. These isolates should be reported as susceptible to Imipenem/meropenem according to CLSI and EUCAST recommendations. Quality Control DIATABS POSITIVE NEGATIVE Imipenem + Indicator (CARB) Klebsiella pneumoniae BAA 1705 E. coli ATCC References Nordmann P et al. Rapid detection of carbapenemase producing Enterobacteriaceae. Emerg. Infect. Dis. 18, 13-17, Nordmann P et al. Rapid detection of carbapenemase production in Pseudomonas. Presentation CI-078, ICAAC, Tijet N et al:" Evaluation of the Carba NP Test for rapid detection of carbapenemase-producing Enterobacteriaceae and Ps aeruginosa." Antimicr Ag. Chemother 57, , All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Rapid CARB Ref Okt. 2013

26 Rapid ESBL Screen Kit Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for in vitro screening of ESBL producing bacteria. The method is valid for Enterobacteriaceae. Content and formulation One vial with 6 mm tablets; Cefotaxime + Indicator (ESBL) Diatabs, formulated for maximum stability, each containing tablets equivalent to a total of tests. One vial with 6 mm. tablets: Cefotaxime + Tazobactam + Indicator (ESBL) Diatabs, tablets. Interpretation of results A change of color from red to yellow indicates a positive reaction. If the reaction is positive after 30 minutes or 1 hour, it is not necessary to incubate further. The tube must be incubated for no more than 2 hours, because positive reactions may fade out. Quality Control DIATABS Positive Negative Enterobacter cloacae NCTC E. coli ATCC Cefotaxime + Indicator Yellow Red Cefotaxime + Tazo + indicator Red Red References Nordmann P et al. Rapid detection of Extended-spectrum-beta-lactamase-producing Enterobacteriaceae. J.Clin Microbiol., , All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Rapid ESBL Ref Jan. 2014

27 Total Metallo-β-Lactamase Confirm Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Tablets are used for qualitative in vitro identification of microbial resistance mechanisms by the agar tablet/disc diffusion method, in order to confirm the mechanism by which the organism has gained resistance to specific antimicrobial agents. Content and formulation 5 cartridges of tablets, formulated for maximum stability, each containing approximately tablets: Meropenem 10 µg, coded MRP10 Dipicolinic acid, coded DPA Imipenem 10 µg, coded IMI10 All products from Rosco Imipenem 10 µg + DPA, coded IM+DP Diagnostica A/S are Imipenem 10 µg + EDTA, coded IM10E marked in compliance Quality Control As positive Q. C. stains the following may be used: Klebs. pneumoniae NCTC 13438, MBL positive Klebs. pneumoniae ATCC BAA-2146, MBL positive References with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. Dongeun Yong et al: Evaluation of double-disk potentiation tests using Dipicolinic acid for detection of MBL-producing Pseudomonas spp and Acinetobacter spp. J. Clin. Microbiol, , Miriagou V et al: Detecting VIM-1 production in P. mirabilis by an Imipenem-Dipicolinic acid double disk synergy test: J. Clin Microbiol 48, , 2010 Enterobacteriaceae MBL MBL Meropenem 10 µg MRP10 Imipenem 10 µg IMI10 DPA Imipenem + DPA IM+DP Imipenem + EDTA IM10E Synergism - - Synergism 5 mm 10 mm Pseudomonas aeruginosa. Mc Conkey agar Acinetobacter spp. Mc Conkey agar MBL MBL Imipenem 10 µg IMI10 Meropenem 10 µg MRP10 DPA Synergism Imipenem + DPA IM+DP 5 mm or Imipenem + EDTA IM10E 10 mm Synergism - - Total Metallo-β-Lactamase Confirm Ref Okt. 2013

28 Okt.2013 Neo-Sensitabs - a Unique Solution Unique characteristics ensure that NEO-SENSITABS are ideal for use in the clinic Rosco Diagnostica A/S is the leader in the field of phenotypic methods for detection of Susceptibility testing with NEO-SENSITABS practice is performed according to CLSI and EUCAST guidelines. For the Neo-Sensitabs marked 2-8 C the following applies: Unopened cartridges in stock Store in a refrigerator at 2-8 C Cartridges opened and in use Use and store at room temperature within 2 months. For all other Neo-Sensitabs: Unopened cartridges in stock Cartridges opened and in use Rosco Dispensers 7 cartridges round Petri dishes of 9 cm diameter 12 cartridges round Petri dishes of cm diameter 16 cartridges square Petri dishes of 12 x 12 cm Store at room temperature Use and store at room temperature within 12 months. REF. No All products from Rosco Diagnostica A/S are marked in compliance with the European Union directive 98/79/EC for In Vitro Diagnostic Medical Devices. For convenient and accurate dispensing of one or a few tablets at a time, use this handy single cartridge dispenser. References Justesen U.S et al:" Comparison of Rosco Neo-Sensitabs with Oxoid paper disks in EUCAST disk diffusion antimicrobial susceptibility testing on Mueller-Hinton agar".eur J Clin Microbiol Infect Dis 32, , Rosco User s Guides The User s Guide contains comprehensive data and information on several subjects. NEO-SENSITABS EUCAST-and CLSI potency NEO-SENSITABS DETECTION OF RESISTANCE MECHANISMS REGRESSION LINES NEO-SENSITABS The contents are continuously updated the latest edition is from Freely available on the Rosco website can be read or downloaded. Rosco Diagnostica A/S also produces Diatabs a range of enzymatic tests for rapid identification and differentiation of bacterial species.

EUCAST recommended strains for internal quality control

EUCAST recommended strains for internal quality control EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC

More information

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Routine internal quality control as recommended by EUCAST Version 3.1, valid from Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The

More information

EUCAST-and CLSI potency NEO-SENSITABS

EUCAST-and CLSI potency NEO-SENSITABS EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme

More information

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines Compliance of manufacturers of AST materials and devices with EUCAST guidelines Data are based on questionnaires to manufacturers of materials and devices for antimicrobial susceptibility testing. The

More information

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to

More information

What s new in EUCAST methods?

What s new in EUCAST methods? What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests

More information

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ... SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* The next-generation MicroScan WalkAway System combines proven technology and reliability with enhanced ease-of-use features to streamline

More information

AMR Industry Alliance Antibiotic Discharge Targets

AMR Industry Alliance Antibiotic Discharge Targets AMR Industry Alliance Antibiotic Discharge Targets List of Predicted No-Effect Concentrations (PNECs) The members of the AMR Industry Alliance have developed a unified approach to establishing discharge

More information

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory

More information

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services 2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens

More information

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2017 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Product Catalogue 2017 Clinical and Industrial Microbiology

Product Catalogue 2017 Clinical and Industrial Microbiology Antibiotic discs in cartridge Description µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2. AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony

More information

2015 Antibiotic Susceptibility Report

2015 Antibiotic Susceptibility Report Citrobacter freundii Enterobacter aerogenes Enterobacter cloacae Escherichia coli Haemophilus influenzenza Klebsiella oxytoca Klebsiella pneumoniae Proteus mirabilis Pseudomonas aeruginosa Serratia marcescens

More information

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose 2016 Antibiogram Central Zone Alberta Health Services including Red Deer Regional Hospital St. Mary s Hospital, Camrose Introduction This antibiogram is a cumulative report of the antimicrobial susceptibility

More information

Intrinsic, implied and default resistance

Intrinsic, implied and default resistance Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been

More information

Product Catalogue 2016 Clinical and Industrial Microbiology

Product Catalogue 2016 Clinical and Industrial Microbiology Antibiotic discs in cartridge Description μg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Ref. Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs

More information

2016 Antibiotic Susceptibility Report

2016 Antibiotic Susceptibility Report Fairview Northland Medical Center and Elk River, Milaca, Princeton and Zimmerman Clinics 2016 Antibiotic Susceptibility Report GRAM-NEGATIVE ORGANISMS 2016 Gram-Negative Non-Urine The number of isolates

More information

EUCAST-and CLSI potency NEO-SENSITABS Main index

EUCAST-and CLSI potency NEO-SENSITABS Main index EUCASTand CLSI potency NEOSENSITABS Main index Page 1 / 2 Index: 0.0.0 Overview of all documents No Subject Rev. date Document 1 Performance of Susceptibility Testing Front page and preface 29112012 1.1.0

More information

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical

More information

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Susceptibility Testing: Advanced Course Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to

More information

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine 2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton

More information

January 2014 Vol. 34 No. 1

January 2014 Vol. 34 No. 1 January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton

More information

Antimicrobial Susceptibility Testing: The Basics

Antimicrobial Susceptibility Testing: The Basics Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories

More information

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...

More information

Performance Information. Vet use only

Performance Information. Vet use only Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.

More information

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products

MASTDISCS AST. Leading the field with a complete solution for AST and Identification disc testing. Comprehensive range. Premium quality products IVD solutions through partnership MASTDISCS AST Leading the field with a complete solution for AST and Identification disc testing Comprehensive range Premium quality products Compatible with EUCAST and

More information

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital 2009 ANTIBIOGRAM University of Alberta Hospital and the Stollery Childrens Hospital Division of Medical Microbiology Department of Laboratory Medicine and Pathology 2 Table of Contents Page Introduction.....

More information

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on

More information

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital 2010 ANTIBIOGRAM University of Alberta Hospital and the Stollery Children s Hospital Medical Microbiology Department of Laboratory Medicine and Pathology Table of Contents Page Introduction..... 2 Antibiogram

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA

More information

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be

More information

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه

More information

56 Clinical and Laboratory Standards Institute. All rights reserved.

56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which

More information

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development

More information

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016 Mercy Medical Center Des Moines, Iowa Department of Pathology Microbiology Department Antibiotic Susceptibility January December 2016 These statistics are intended solely as a GUIDE to choosing appropriate

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

Mechanism of antibiotic resistance

Mechanism of antibiotic resistance Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance

More information

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents Journal of Antimicrobial Chemotherapy (5) 35, -5 Brief reports Heat stability of the antimicrobial activity of sixty-two antibacterial agents Walter H. Traub and Birgit Leonhard Institut fur Medizinische

More information

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS

MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS. MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS MicroScan Microbiology Systems MORE CHOICES MORE ANSWERS MicroScan GRAM NEGATIVE AND GRAM POSITIVE PANELS LABORATORIES ON THE FRONT LINE From the National Action Plan for Combating Antibiotic Resistant

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and

More information

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review (1) Have all important studies/evidence of which you are aware been included in the application? Yes No Please provide brief comments on any relevant studies that have not been included: (2) For each of

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy Standing Committee on Susceptibility Testing Version 13.0, 10-06-2014 Content Page Additional information Changes in version 13 2 Suggestions for appropriate

More information

Antimicrobial susceptibility

Antimicrobial susceptibility Antimicrobial susceptibility PATTERNS Microbiology Department Canterbury ealth Laboratories and Clinical Pharmacology Department Canterbury District ealth Board March 2011 Contents Preface... Page 1 ANTIMICROBIAL

More information

Antimicrobial Resistance Strains

Antimicrobial Resistance Strains Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant

More information

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Antibiotic Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting Any substance of natural, synthetic or semisynthetic origin which at low concentrations kills or inhibits the growth of bacteria

More information

Main objectives of the EURL EQAS s

Main objectives of the EURL EQAS s EQAS Enterococci, Staphylococci and E. coli EURL workshop, April, 11 Lourdes García Migura Main objectives of the EURL EQAS s To improve the comparability of antimicrobial susceptibility testing (AST)

More information

Concise Antibiogram Toolkit Background

Concise Antibiogram Toolkit Background Background This toolkit is designed to guide nursing homes in creating their own antibiograms, an important tool for guiding empiric antimicrobial therapy. Information about antibiograms and instructions

More information

EARS Net Report, Quarter

EARS Net Report, Quarter EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased

More information

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland,

Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, Non-Susceptibility of Bacterial Pathogens Causing Hospital-Onset Pneumonia UK and Ireland, 2008-2016 Alicia Russell Federation of Infection Societies conference 14 th November 2018 alisia_russell BSAC

More information

2 New products for 2014

2 New products for 2014 2 New products for 2014 Group B Streptococci Testing Thermo Scientific Brilliance GBS Agar Thermo Scientific TM Brilliance GBS Agar is a clear, selective chromogenic medium for the presumptive identification

More information

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method. OBJECTIVES 1. Compare the antimicrobial capabilities of different antibiotics. 2. Compare effectiveness of with different types of bacteria.

More information

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics. Ref: FOI/CAD/ID 3459 27 June 2017 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME16 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act

More information

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes

Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Interpreting Microbiology reports for better Clinical Decisions Interpreting Antibiogrammes Prof C. Wattal Hon. Sr. Consultant & Chairman Dept. of Clinical Microbiology Sir Ganga Ram Hospital New Delhi

More information

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical

More information

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,

More information

HUSRES Annual Report 2007 Martti Vaara.

HUSRES Annual Report 2007 Martti Vaara. HUSRES Annual Report 2007 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2007 report is the HUSLAB/Whonet database 2007, which contains susceptibility data on about 182.000 bacteria

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007

More information

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...

More information

BSAC standardized disc susceptibility testing method (version 8)

BSAC standardized disc susceptibility testing method (version 8) Journal of Antimicrobial Chemotherapy (2009) 64, 454 489 doi:10.1093/jac/dkp244 Advance Access publication 8 July 2009 BSAC standardized disc susceptibility testing method (version 8) J. M. Andrews* for

More information

Background and Plan of Analysis

Background and Plan of Analysis ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

More information

Version 1.01 (01/10/2016)

Version 1.01 (01/10/2016) CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be

More information

CONTAGIOUS COMMENTS Department of Epidemiology

CONTAGIOUS COMMENTS Department of Epidemiology VOLUME XXIX NUMBER 3 November 2014 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Marti Roe SM MLS (ASCP), Sarah Parker MD, Jason Child PharmD, and Samuel R.

More information

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance

More information

Antimicrobial Susceptibility Patterns

Antimicrobial Susceptibility Patterns Antimicrobial Susceptibility Patterns KNH SURGERY Department Masika M.M. Department of Medical Microbiology, UoN Medicines & Therapeutics Committee, KNH Outline Methodology Overall KNH data Surgery department

More information

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups Gunnar Kahlmeter, Derek Brown Izmir, February 2011 Anaerobes subcommittee EUCAST Subcommittee on breakpoints

More information

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Taiwan Surveillance of Antimicrobial Resistance (TSAR) Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,

More information

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR: Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &

More information

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter

More information

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker

The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial

More information

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient 1 Chapter 79, Self-Assessment Questions 1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient with normal renal function is: A. Trimethoprim-sulfamethoxazole B. Cefuroxime

More information

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase

More information

Understanding the Hospital Antibiogram

Understanding the Hospital Antibiogram Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital

More information

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information

More information

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India ISSN: 2319-7706 Volume 4 Number 11 (2015) pp. 731-736 http://www.ijcmas.com Original Research Article Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching

More information

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER University of Minnesota Health University of Minnesota Medical Center University of Minnesota Masonic Children s Hospital May 2017 Printed herein are

More information

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production

More information

Quality assurance of antimicrobial susceptibility testing

Quality assurance of antimicrobial susceptibility testing Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly

More information

GENERAL NOTES: 2016 site of infection type of organism location of the patient

GENERAL NOTES: 2016 site of infection type of organism location of the patient GENERAL NOTES: This is a summary of the antibiotic sensitivity profile of clinical isolates recovered at AIIMS Bhopal Hospital during the year 2016. However, for organisms in which < 30 isolates were recovered

More information

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges Janet Hindler, MCLS MT(ASCP) UCLA Medical Center jhindler@ucla.edu also working as a consultant with the Association

More information

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31

More information

RCH antibiotic susceptibility data

RCH antibiotic susceptibility data RCH antibiotic susceptibility data The following represent RCH antibiotic susceptibility data from 2008. This data is used to inform antibiotic guidelines used at RCH. The data includes all microbiological

More information

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018 Antimicrobial Update Alison MacDonald Area Antimicrobial Pharmacist NHS Highland alisonc.macdonald@nhs.net April 2018 Starter Questions Setting the scene... What if antibiotics were no longer effective?

More information

Mongolia September 2012

Mongolia September 2012 MICROBIOLOGY: bacterial resistance Roßburg / 9.9.22 MVZ DORTMUND - Dr.Eberhard u. Partner - MICROBIOLOGY bacterial resistance control, role of the laboratory MIKROBIOLOGY www.labmed.de / mikro@labmed.de

More information

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

More information

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester

Breaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester Breaking the Ring β-lactamases and the Great Arms Race Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester 2015 MFMER slide-1 Disclosures I have no relevant financial relationships

More information

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic

More information

Available online at ISSN No:

Available online at  ISSN No: Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other

More information

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Pseudomonas aeruginosa (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.) Description: Greenish gray colonies with some beta-hemolysis around each colony on blood agar (BAP),

More information

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance

More information

APPENDIX III - DOUBLE DISK TEST FOR ESBL

APPENDIX III - DOUBLE DISK TEST FOR ESBL Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January

More information

This document is protected by international copyright laws.

This document is protected by international copyright laws. Table 2C Table 2C. and s for Product Name: Infobase 2010 - Release Date: February 2010 60 Clinical and Laboratory Standards Institute. All rights reserved. Testing Conditions Medium: diffusion: MHA Broth

More information

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO) Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health

More information

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections Vol.1 No.2 Oct-Dec 2013 ISSN : 2321-6387 Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections S. Yogeshpriya*, Usha N.Pillai, S. Ajithkumar and N. Madhavan Unny Department

More information